title: SNX2-ABL1-positive acute lymphoblastic leukemia possibly has a poor prognosis.
authors.affiliation: a Laboratory of Stem Cell Transplantation , Ningbo First Hospital , Zhejiang , P.R. China.
authors.forename: Qitian
authors.initials: Q
authors.lastname: Mu
authors.affiliation: b Department of Oncology , Eastern Hepatobiliary Hospital, Third Affiliated Hospital of Second Military Medical University , Shanghai , P.R. China.
authors.forename: Lieping
authors.initials: L
authors.lastname: Guo
authors.affiliation: c Bone Marrow Transplantation Center , The First Affiliated Hospital, School of Medicine, Zhejiang University , Hangzhou , P.R. China.
authors.forename: Yongxian
authors.initials: Y
authors.lastname: Hu
authors.affiliation: d Hematology Department , Ningbo First Hospital , Zhejiang , P.R. China.
authors.forename: Lixia
authors.initials: L
authors.lastname: Sheng
authors.affiliation: a Laboratory of Stem Cell Transplantation , Ningbo First Hospital , Zhejiang , P.R. China.
authors.forename: Yi
authors.initials: Y
authors.lastname: Zhang
authors.affiliation: a Laboratory of Stem Cell Transplantation , Ningbo First Hospital , Zhejiang , P.R. China.
authors.forename: Ningning
authors.initials: N
authors.lastname: Wu
authors.affiliation: a Laboratory of Stem Cell Transplantation , Ningbo First Hospital , Zhejiang , P.R. China.
authors.forename: Ying
authors.initials: Y
authors.lastname: Chen
authors.affiliation: a Laboratory of Stem Cell Transplantation , Ningbo First Hospital , Zhejiang , P.R. China.
authors.forename: Cong
authors.initials: C
authors.lastname: Shi
authors.affiliation: a Laboratory of Stem Cell Transplantation , Ningbo First Hospital , Zhejiang , P.R. China.
authors.forename: Songqiu
authors.initials: S
authors.lastname: Shi
authors.affiliation: a Laboratory of Stem Cell Transplantation , Ningbo First Hospital , Zhejiang , P.R. China.
authors.forename: Ying
authors.initials: Y
authors.lastname: Wu
authors.affiliation: a Laboratory of Stem Cell Transplantation , Ningbo First Hospital , Zhejiang , P.R. China.|d Hematology Department , Ningbo First Hospital , Zhejiang , P.R. China.
authors.forename: Guifang
authors.initials: G
authors.lastname: Ouyang
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D014408:Biomarkers, Tumor; D004252:DNA Mutational Analysis; D017809:Fatal Outcome; D018628:Gene Dosage; D005838:Genotype; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000235:genetics* / Q000401:mortality* / Q000628:therapy; D011379:Prognosis; D016315:Proto-Oncogene Proteins c-abl / Q000235:genetics*; D058305:Sorting Nexins / Q000235:genetics*; D014178:Translocation, Genetic
chemical_list: D014408:Biomarkers, Tumor; D015514:Oncogene Proteins, Fusion; C513979:SNX2 protein, human; D058305:Sorting Nexins; D016315:Proto-Oncogene Proteins c-abl